Revenue surged 42.95% to RMB 21.61 billion and net profit more than doubled, driven by expanded production and higher prices in key nutrition products. The company strengthened its global presence, invested heavily in R&D, and distributed a special dividend while maintaining robust cash flow.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.